mesalamine has been researched along with Clostridioides difficile Infection in 4 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This leads us to establish how rCDI and its resistance to different treatments make this a challenge for the health system, both for hospitals and for outpatients, as well as how time-consuming each treatment is from the first intake of the drug until its total efficacy or until patients reach a dose-response and time-response to the disease." | 1.91 | Recurrent Multidrug-Resistant ( Castells, J; Ibrahimli, S; Jaramillo, AP; Siegel, S, 2023) |
| "Recurrent Clostridium difficile infection (rCDI) contributes to a significant burden of disease in patients with inflammatory bowel disease (IBD)." | 1.43 | Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study. ( Bahreini, Z; McGeer, A; Nguyen, GC; Razik, R; Rumman, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaramillo, AP | 1 |
| Castells, J | 1 |
| Ibrahimli, S | 1 |
| Siegel, S | 1 |
| Viazis, N | 1 |
| Pontas, C | 1 |
| Karmiris, K | 1 |
| Dimas, I | 1 |
| Fragaki, M | 1 |
| Paspatis, G | 1 |
| Drygiannakis, I | 1 |
| Koutroubakis, IE | 1 |
| Moschovis, D | 1 |
| Tzouvala, M | 1 |
| Theocharis, G | 1 |
| Tsolias, C | 1 |
| Thomopoulos, K | 1 |
| Zampeli, E | 1 |
| Axiaris, G | 1 |
| Michopoulos, S | 1 |
| Belesiotou, E | 1 |
| Banasa, M | 1 |
| Maraki, S | 1 |
| Kouskoumpekou, F | 1 |
| Apostolopoulos, G | 1 |
| Stamouli, V | 1 |
| Prifti, H | 1 |
| Mantzaris, GJ | 1 |
| Razik, R | 1 |
| Rumman, A | 1 |
| Bahreini, Z | 1 |
| McGeer, A | 1 |
| Nguyen, GC | 1 |
| Thalhammer, F | 1 |
| Hollenstein, U | 1 |
| Janata, K | 1 |
| Knapp, S | 1 |
| Koller, R | 1 |
| Locker, GJ | 1 |
| Staudinger, T | 1 |
| Sunder-Plassmann, G | 1 |
| Frass, M | 1 |
| Burgmann, H | 1 |
4 other studies available for mesalamine and Clostridioides difficile Infection
| Article | Year |
|---|---|
Recurrent Multidrug-Resistant
Topics: Adalimumab; Anti-Bacterial Agents; Clostridium Infections; Colitis, Ulcerative; Female; Humans; Mesa | 2023 |
Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bacteri | 2019 |
Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Topics: Adalimumab; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clostridioides difficile; | 2016 |
A coincidence of disastrous accidents: Crohn's disease, agranulocytosis, and Clostridium septicum infection.
Topics: Adult; Agranulocytosis; Aminosalicylic Acids; Amputation, Surgical; Anti-Inflammatory Agents, Non-St | 1997 |